Contemporary Assessment and Pharmacotherapy of Tourette Syndrome

Lawrence Scahill*, Gerald Erenberg, Cheston M. Berlin, Cathy Budman, Barbara J. Coffey, Joseph Jankovic, Louise Kiessling, Robert A. King, Roger Kurlan, Anthony Lang, Jonathan Mink, Tanya Murphy, Samual Zinner, John Walkup

*Corresponding author for this work

Research output: Contribution to journalArticle

182 Citations (Scopus)

Abstract

Summary: To develop a guide to clinical assessment and pharmacotherapy for children and adults with Tourette syndrome (TS), we reviewed published literature over the past 25 years to identify original articles and reviews on the assessment and pharmacological treatment of Tourette syndrome, attention-deficit/hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD). The literature search also included a survey of reviews published in book chapters. The assessment section was compiled from several reviews. Pharmacological treatments were classified into those with strong empirical support (as evidenced by two positive placebo-controlled studies for tics, OCD, or ADHD in TS samples); modest empirical support (one positive placebo-controlled study), or minimal support (open-label data only). We conclude that accurate diagnosis, including identification of comorbid conditions, is an essential step toward appropriate treatment for patients with TS. In many patients with TS, symptom management requires pharmacotherapy for tics or coexisting conditions. The evidence supporting efficacy and safety for medications used in patients with TS varies. But this evidence offers the best guide to clinical practice.

Original languageEnglish (US)
Pages (from-to)192-206
Number of pages15
JournalNeuroRx
Volume3
Issue number2
DOIs
StatePublished - Apr 1 2006

Fingerprint

Tourette Syndrome
Drug Therapy
Tics
Obsessive-Compulsive Disorder
Attention Deficit Disorder with Hyperactivity
Placebos
Pharmacology
Therapeutics
Safety

Keywords

  • ADHD
  • OCD
  • Tourette syndrome
  • pharmacotherapy

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Scahill, L., Erenberg, G., Berlin, C. M., Budman, C., Coffey, B. J., Jankovic, J., ... Walkup, J. (2006). Contemporary Assessment and Pharmacotherapy of Tourette Syndrome. NeuroRx, 3(2), 192-206. https://doi.org/10.1016/j.nurx.2006.01.009
Scahill, Lawrence ; Erenberg, Gerald ; Berlin, Cheston M. ; Budman, Cathy ; Coffey, Barbara J. ; Jankovic, Joseph ; Kiessling, Louise ; King, Robert A. ; Kurlan, Roger ; Lang, Anthony ; Mink, Jonathan ; Murphy, Tanya ; Zinner, Samual ; Walkup, John. / Contemporary Assessment and Pharmacotherapy of Tourette Syndrome. In: NeuroRx. 2006 ; Vol. 3, No. 2. pp. 192-206.
@article{ce2fe4617be64a8d860684d4db68bd78,
title = "Contemporary Assessment and Pharmacotherapy of Tourette Syndrome",
abstract = "Summary: To develop a guide to clinical assessment and pharmacotherapy for children and adults with Tourette syndrome (TS), we reviewed published literature over the past 25 years to identify original articles and reviews on the assessment and pharmacological treatment of Tourette syndrome, attention-deficit/hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD). The literature search also included a survey of reviews published in book chapters. The assessment section was compiled from several reviews. Pharmacological treatments were classified into those with strong empirical support (as evidenced by two positive placebo-controlled studies for tics, OCD, or ADHD in TS samples); modest empirical support (one positive placebo-controlled study), or minimal support (open-label data only). We conclude that accurate diagnosis, including identification of comorbid conditions, is an essential step toward appropriate treatment for patients with TS. In many patients with TS, symptom management requires pharmacotherapy for tics or coexisting conditions. The evidence supporting efficacy and safety for medications used in patients with TS varies. But this evidence offers the best guide to clinical practice.",
keywords = "ADHD, OCD, Tourette syndrome, pharmacotherapy",
author = "Lawrence Scahill and Gerald Erenberg and Berlin, {Cheston M.} and Cathy Budman and Coffey, {Barbara J.} and Joseph Jankovic and Louise Kiessling and King, {Robert A.} and Roger Kurlan and Anthony Lang and Jonathan Mink and Tanya Murphy and Samual Zinner and John Walkup",
year = "2006",
month = "4",
day = "1",
doi = "10.1016/j.nurx.2006.01.009",
language = "English (US)",
volume = "3",
pages = "192--206",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "2",

}

Scahill, L, Erenberg, G, Berlin, CM, Budman, C, Coffey, BJ, Jankovic, J, Kiessling, L, King, RA, Kurlan, R, Lang, A, Mink, J, Murphy, T, Zinner, S & Walkup, J 2006, 'Contemporary Assessment and Pharmacotherapy of Tourette Syndrome', NeuroRx, vol. 3, no. 2, pp. 192-206. https://doi.org/10.1016/j.nurx.2006.01.009

Contemporary Assessment and Pharmacotherapy of Tourette Syndrome. / Scahill, Lawrence; Erenberg, Gerald; Berlin, Cheston M.; Budman, Cathy; Coffey, Barbara J.; Jankovic, Joseph; Kiessling, Louise; King, Robert A.; Kurlan, Roger; Lang, Anthony; Mink, Jonathan; Murphy, Tanya; Zinner, Samual; Walkup, John.

In: NeuroRx, Vol. 3, No. 2, 01.04.2006, p. 192-206.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Contemporary Assessment and Pharmacotherapy of Tourette Syndrome

AU - Scahill, Lawrence

AU - Erenberg, Gerald

AU - Berlin, Cheston M.

AU - Budman, Cathy

AU - Coffey, Barbara J.

AU - Jankovic, Joseph

AU - Kiessling, Louise

AU - King, Robert A.

AU - Kurlan, Roger

AU - Lang, Anthony

AU - Mink, Jonathan

AU - Murphy, Tanya

AU - Zinner, Samual

AU - Walkup, John

PY - 2006/4/1

Y1 - 2006/4/1

N2 - Summary: To develop a guide to clinical assessment and pharmacotherapy for children and adults with Tourette syndrome (TS), we reviewed published literature over the past 25 years to identify original articles and reviews on the assessment and pharmacological treatment of Tourette syndrome, attention-deficit/hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD). The literature search also included a survey of reviews published in book chapters. The assessment section was compiled from several reviews. Pharmacological treatments were classified into those with strong empirical support (as evidenced by two positive placebo-controlled studies for tics, OCD, or ADHD in TS samples); modest empirical support (one positive placebo-controlled study), or minimal support (open-label data only). We conclude that accurate diagnosis, including identification of comorbid conditions, is an essential step toward appropriate treatment for patients with TS. In many patients with TS, symptom management requires pharmacotherapy for tics or coexisting conditions. The evidence supporting efficacy and safety for medications used in patients with TS varies. But this evidence offers the best guide to clinical practice.

AB - Summary: To develop a guide to clinical assessment and pharmacotherapy for children and adults with Tourette syndrome (TS), we reviewed published literature over the past 25 years to identify original articles and reviews on the assessment and pharmacological treatment of Tourette syndrome, attention-deficit/hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD). The literature search also included a survey of reviews published in book chapters. The assessment section was compiled from several reviews. Pharmacological treatments were classified into those with strong empirical support (as evidenced by two positive placebo-controlled studies for tics, OCD, or ADHD in TS samples); modest empirical support (one positive placebo-controlled study), or minimal support (open-label data only). We conclude that accurate diagnosis, including identification of comorbid conditions, is an essential step toward appropriate treatment for patients with TS. In many patients with TS, symptom management requires pharmacotherapy for tics or coexisting conditions. The evidence supporting efficacy and safety for medications used in patients with TS varies. But this evidence offers the best guide to clinical practice.

KW - ADHD

KW - OCD

KW - Tourette syndrome

KW - pharmacotherapy

UR - http://www.scopus.com/inward/record.url?scp=33646140119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646140119&partnerID=8YFLogxK

U2 - 10.1016/j.nurx.2006.01.009

DO - 10.1016/j.nurx.2006.01.009

M3 - Article

VL - 3

SP - 192

EP - 206

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 2

ER -

Scahill L, Erenberg G, Berlin CM, Budman C, Coffey BJ, Jankovic J et al. Contemporary Assessment and Pharmacotherapy of Tourette Syndrome. NeuroRx. 2006 Apr 1;3(2):192-206. https://doi.org/10.1016/j.nurx.2006.01.009